Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorLeblebicioglu, Hakan
dc.contributor.authorSünbül, Mustafa
dc.contributor.authorBarut, Şener
dc.contributor.authorBüyüktuna, Seyit Ali
dc.contributor.authorÖzkurt, Zülal
dc.contributor.authorYapar, Derya
dc.contributor.authorYılmaz, Gürdal
dc.contributor.authorGüner, Rahmet
dc.date.accessioned2019-05-10T09:39:36Z
dc.date.available2019-05-10T09:39:36Z
dc.date.issued2016
dc.identifier.citationLeblebicioglu, H., Sunbul, M., Barut, S., Buyuktuna, S. A., Ozkurt, Z., Yapar, D., ... & Murat, N. (2016). Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever. Antiviral research, 133, 9-13.en_US
dc.identifier.issn0166-3542
dc.identifier.urihttps://doi.org/10.1016/j.antiviral.2016.07.010
dc.identifier.urihttps://hdl.handle.net/11491/736
dc.description.abstractIntroduction The information of discharge criteria in patients with Crimean-Congo Hemorrhagic Fever (CCHF) is limited. In this study, we aimed to determine the clinical and laboratory parameters used in discharging the patients by the experienced centers. Materials and methods The study was done in 9 reference centers of CCHF from May 1, 2015 to December 1, 2015 and included laboratory-confirmed patients with CCHF. The study was prospective, observational and non-interventional. Results The study included 260 patients. Mean age was 51.3 ± 16.3 years; 158 (60.8%) were male. Mean hospital stay was 7 ± 2.6 days. The decision of discharging was taken considering clinical and laboratory findings. On discharge, no patients had fever or hemorrhage. The patients were followed-up clinically and a repeat CCHF PCR was not studied. All centers considered the following criteria for discharge: no fever and hemorrhage, improvement in clinical findings and laboratory studies. For all patients except one, platelet count was >50,000/mm3 and had a tendency to increase. Prothrombin time and international normalized ratio (INR) were normal in 258 (99.6%) and 254 (98.1%) patients respectively. Alanine aminotransferase (ALT) was either normal or not higher than 10-fold and had a tendency to decrease in 259 (99.6%) patients. ALT and aspartate aminotransferase (AST) levels were not taken as discharge criteria with priority. During 30 days following the discharge, complication, relapse, or secondary transmission were not reported. Conclusions The discharging practice of the centers based on clinical and laboratory parameters seems safe considering no complications, relapses, or secondary infection thereafter. Current discharge practice of the centers composed of no fever and hemorrhage, improvement in clinical findings, platelet count of either >100,000/mm3 or >50,000/mm3 with a tendency to increase, and normal bleeding tests can be used as the criteria of discharge. © 2016 Elsevier B.V.en_US
dc.language.isoeng
dc.publisherElsevier B.V.en_US
dc.relation.isversionof10.1016/j.antiviral.2016.07.010en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCrimean-Congo Hemorrhagic Feveren_US
dc.subjectDischarge Dispositionen_US
dc.subjectReported Outcomesen_US
dc.titleMulti-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Feveren_US
dc.typearticleen_US
dc.relation.journalAntiviral Researchen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume133en_US
dc.identifier.startpage9en_US
dc.identifier.endpage13en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster